uniQure (QURE) Operating Expenses (2016 - 2026)
uniQure's (QURE) quarterly Operating Expenses came in at $49.5 million in Q1 2026, up 4.69% year-on-year from $47.2 million in Q1 2025, and down 12.96% quarter-over-quarter from $56.8 million in Q4 2025.
uniQure (QURE) Operating Expenses (2016 - 2026) Analysis & Trends
uniQure's Operating Expenses history runs 11 years deep, the most recent figure standing at $49.5 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 4.69% year-over-year to $49.5 million in Q1 2026; TTM through Mar 2026 was $210.0 million, a 5.99% increase from a year earlier, with the FY2025 full-year figure at $207.8 million, down 3.24% from the prior year.
- Operating Expenses retreated to $49.5 million in Q1 2026 per QURE's latest filing, from $56.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $84.5 million in Q3 2023 and bottomed at $43.2 million in Q3 2024.
- The 5-year median for Operating Expenses is $56.9 million (2024), against an average of $60.7 million.
- Across the five-year window, Operating Expenses jumped 44.83% in 2023 and tumbled 48.87% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $78.2 million in 2022, then fell by 11.88% to $68.9 million in 2023, then dropped by 26.26% to $50.8 million in 2024, then grew by 11.79% to $56.8 million in 2025, then decreased by 12.96% to $49.5 million in 2026.
- Per Business Quant, the three latest QURE Operating Expenses figures stand at $49.5 million (Q1 2026), $56.8 million (Q4 2025), and $54.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | uniQure | 2.42 Bn | 2.42 Bn | 3.34 Mn | 49.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.46 Mn |
| Dec 31, 2025 | 56.83 Mn |
| Sep 30, 2025 | 54.20 Mn |
| Jun 30, 2025 | 49.54 Mn |
| Mar 31, 2025 | 47.25 Mn |
| Dec 31, 2024 | 50.84 Mn |
| Sep 30, 2024 | 43.19 Mn |
| Jun 30, 2024 | 56.88 Mn |
| Mar 31, 2024 | 63.86 Mn |
| Dec 31, 2023 | 68.94 Mn |
| Sep 30, 2023 | 84.48 Mn |
| Jun 30, 2023 | 68.57 Mn |
| Mar 31, 2023 | 81.09 Mn |
| Dec 31, 2022 | 78.24 Mn |
| Sep 30, 2022 | 62.25 Mn |
| Jun 30, 2022 | 59.52 Mn |
| Mar 31, 2022 | 55.99 Mn |
| Dec 31, 2021 | 58.10 Mn |
| Sep 30, 2021 | 48.46 Mn |
| Jun 30, 2021 | 73.22 Mn |